Prolactin in human systemic lupus erythematosus

Lupus

Volumn 10, Issue 10, 2001, Pages 748-756

  Jara, L J ^a   Vera Lastra, O ^a   Miranda, J M ^a   Alcala, M ^a   Alvarez Nemegyei, J ^a  

^a HOSPITAL DE ESPECIALIDADES   (Mexico)

Author keywords

Organ system involvement; Prolactin; Systemic lupus erythematosus

Indexed keywords

DOPAMINE; INTERLEUKIN 6; PROLACTIN;

AUTOIMMUNITY; CEREBROSPINAL FLUID; DISEASE ACTIVITY; DISEASE ASSOCIATION; DOPAMINE METABOLISM; ENCEPHALITIS; HUMAN; HYPERPROLACTINEMIA; IMMUNE SYSTEM; LUPUS ERYTHEMATOSUS NEPHRITIS; MICROADENOMA; PATHOGENESIS; PREGNANCY; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTIN RELEASE; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; URINE LEVEL;

AUTOANTIBODIES; CENTRAL NERVOUS SYSTEM; HUMANS; HYPERPROLACTINEMIA; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; ORGAN SPECIFICITY; PROLACTIN;

EID: 0034753976     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/096120301717164994     Document Type: Review

References (85)

1. The stress response and the regulation of inflammatory disease
2. Neuroendocrine-immune system interactions and autoimmunity
3. Neuroendocrine-immune interactions
4. Immune-neuroendocrine interactions. Facts and hypothesis
5. A molecular basis for bidirectional communication between the immune and neuroendocrine systems
6. Prolactin immunoregulation, and autoimmune diseases
7. Prolactin: A stimulator of disease activity in systemic lupus erythematosus
8. Roles of prolactin and gonadotropin-releasing hormone in rheumatic diseases
9. Sex hormone modulation of autoimmunity in NZB/NZW mice
10. Sex hormones and systemic lupus erythematosus
11. Prolactin influences autoimmune disease activity in the female B/W mouse
12. Does prolactin have a role in the pathogenesis of systemic lupus erythematosus'?
13. Correlation study between prolactin and androgens in male patients with systemic lupus erythematosus
14. Prolactin and gonadal hormones during pregnancy in systemic lupus erythematosus
15. A new endocrinological and immunological syndrome in SLE: Elevation of human chorionic gonadotropin and of antibodies against ovary and endometrium antigens
16. Prolactin levels in men with SLE and RA
17. Hyperprolactinemia in systemic lupus erythematosus?
18. Hyperprolactinemia in males with systemic lupus erythematosus
19. Longitudinal analysis of prolactin and disease activity in SLE
20. Hyperprolactinemia in systemic lupus erythematosus (SLE): Association with disease activity
21. No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus
22. Prolactin levels in patients with systemic lupus erythematosus. A case controlled study
23. Prolactin in systemic lupus erythematosus
24. Longstanding hyperprolactinemia associated with systemic lupus erythematosus: Possible hormonal stimulation of an autoimmune disease
25. Elevated serum prolactin or elevated prolactin/cortisol ratio are associated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases
26. Basal and after-stimuli test for prolactinemia in systemic lupus erythematosus
27. Prolactin modulates the disease activity of systemic lupus erythematosus accompanied by prolactinoma
28. Relationship between endocrine, immune, and clinical variables in patients with systemic lupus erythematosus
29. Prolactin-induced immunoglobulin and autoantibody production by peripheral blood mononuclear cells from systemic lupus erythematosus and normal individuals
30. Prolactin enhances the in vitro production of IgG in peripheral blood mononuclear cells from patients with systemic lupus erythematosus but not from healthy controls
31. Association between prolactin and disease activity in systemic lupus erythematosus. Influence of statistical power
32. Functional evaluation on prolactin secretion in patients with hypothalamic-pituitary disorders
33. A monoclonal antibody suitable for the radioimmunoassay for human prolactin
34. Anti-PRL autoantibodies in systemic lupus erythematosus patients with associated hyperprolactinemia
35. The immunoregulatory effects of prolactin are time of day dependent
36. Prolactin: Hyperprolactinemic syndromes and management
37. Hyperprolactinemia in systemic lupus erythematosus: Association with clinical activity
38. Prolactin and systemic lupus erythematosus: Prolactin secretion by SLE lymphocytes and proliferative (autocrine) activity
39. A bioactive 60-kilodalton prolactin species is preferentially secreted in cultures of mitogen-stimulated and nonstimulated peripheral blood mononuclear cells from subjects with systemic lupus erythematosus
40. Hypophysectomized rats depend on residual prolactin for survival
41. Prolactin (PRL) and its receptor: Actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice
42. The prolactin/growth hormone receptor family
43. Specific, high affinity, saturable binding site for the 16-kDa fragment of prolactin on capillary endothelial cells
44. Cellular interactions in the pathogenesis of lupus nephritis: The role of T cells and macrophages in the amplification of the inflammatory process in the kidney
45. T cells and macrophages and their role in renal injury
46. Chemotactic factors and renal inflammation
47. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis
48. Serum and urinary interleukin-6 in systemic lupus erythematosus
49. Clinical significance of serum and urine prolactin levels in lupus glomerulonephritis
50. Prolactin (PRL) and interleukin-6 (IL-6) in severe lupus glomerulonephritis (GN)
51. Bromocriptine restores tolerance in estrogen-treated mice
52. Capillary prolactin measurement for diagnosis of seizures
53. Characterization of prolactin immunoreactivity in human cerebrospinal fluid
54. Characterization of prolactin receptors in human choroid plexus
55. Interleukin-1 and interleukin-6 activities are increased in the cerebrospinal fluid of patients with CNS lupus erythematosus and correlate with local late T-cell activation markers
56. Interferon-alpha in lupus psychosis
57. Intravenous immunoglobulin and bromocriptine in the treatment of refractory neuropsychiatric systemic lupus erythematosus
58. Prolactin hormone in juvenile systemic lupus erythematosus: A possible relationship to disease activity and CNS manifestations
59. Prolactin and interleukin-6 in neuropsychiatric lupus erythematosus
60. Mood states and disease activity in patients with systemic lupus erythematosus treated with bromocriptine
61. Incidence and characteristics of microprolactinomas (3-5mm) in 4199 women assayed for prolactin
62. Premature death with bladder outlet obstruction and hyperprolactinemia in the New Zealand BlackxNew Zealand White mice treated with ethinyl estradiol and 17 beta estradiol
63. Growth of a microprolactinoma to a macroprolactinoma during estrogen therapy
64. The natural history of idiopathic hyperprolactinemia
65. Hyperprolactinemic systemic lupus erythematosus (SLE): 8 additional cases with prolactinomas
66. Does hyperprolactinemia secondary to microadenoma induce autoimmune diseases?
67. Prolactin levels and antinuclear antibody profiles in women tested for connective tissue disease
68. Autoantibody profile in the sera of women with hyperprolactinemia
69. Interleukin-6 stimulates anterior pituitary hormone release in vitro
70. Production of interleukin-6 by anterior pituitary cells
71. Blood to brain transport ofinterleukin links the immune and central nervous systems
72. Serum cortisol and cerebrospinal fluid β-endorphins in status epilepticus
73. Steroid hormones and steroid hormone binding globulins in cerebrospinal fluid studied in individuals with intact and with disturbed blood-cerebrospinal fluid barrier
74. Evidence for a pathological reduction in brain dopamine metabolism in idiopathic hyperprolactinemia
75. Bioactive cyclic of peptides
76. Elevated serum levels of ciclo (His Pro), an endogenous inhibitor of pituitary prolactin secretion, in systemic lupus erythematosus patients
77. Plasma homovanillic acid and prolactin in systemic lupus erythematosus
78. Hyperprolactinemia in acute myeloid leukemia and indication of ectopic expression of human prolactin in blast cells of a patient of subtype M4
79. Expression of prolactin receptors in murine lymphoid cells in normal and autoimmune situations
80. Prolactin-immunoglobulin G complexes from human serum act as co stimulatory ligands causing proliferation of malignant B lymphocyte
81. Allelic markers close to prolactin are associated with HLA-DRB1 susceptibility alleles among women with rheumatoid arthritis and systemic lupus erythematosus
82. Prolactin secreting adenomata are possibly associated with HLA-B8
83. Prolactin locally produced by synovium infiltrating T lymphocytes induces excessive synovial cells functions in patients with rheumatoid arthritis
84. Prolactin up-regulates cathepsin D and D expression in minor salivary glands of patients with Sjogren's syndrome